The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BRCA mutations in metastatic colorectal cancer (mCRC) and response to chemotherapy.
 
Sophie Feng
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai
 
Laith Al-Showbaki
No Relationships to Disclose
 
Monika K. Krzyzanowska
Honoraria - Eisai; Eisai; Eisai; Eisai; Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai
Research Funding - Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
 
Rebecca M. Prince
No Relationships to Disclose
 
Tracy Stockley
Honoraria - Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; Janssen; Janssen; Janssen; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Janssen; Janssen; Janssen; Janssen
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
 
Celeste Yu
No Relationships to Disclose
 
Philippe L. Bedard
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Mersana (Inst); Mersana (Inst); Mersana (Inst); Mersana (Inst); Nektar (Inst); Nektar (Inst); Nektar (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); PTC Therapeutics (Inst); PTC Therapeutics (Inst); PTC Therapeutics (Inst); PTC Therapeutics (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SignalChem (Inst); SignalChem (Inst); SignalChem (Inst); SignalChem (Inst)
 
Lillian L. Siu
No Relationships to Disclose
 
Eric Xueyu Chen
No Relationships to Disclose